BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

394 related articles for article (PubMed ID: 27396545)

  • 1. Risk of nephrolithiasis, hyperoxaluria, and calcium oxalate supersaturation increased after Roux-en-Y gastric bypass surgery: a systematic review and meta-analysis.
    Upala S; Jaruvongvanich V; Sanguankeo A
    Surg Obes Relat Dis; 2016; 12(8):1513-1521. PubMed ID: 27396545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Roux-en-Y gastric bypass is associated with early increased risk factors for development of calcium oxalate nephrolithiasis.
    Duffey BG; Pedro RN; Makhlouf A; Kriedberg C; Stessman M; Hinck B; Ikramuddin S; Kellogg T; Slusarek B; Monga M
    J Am Coll Surg; 2008 Jun; 206(6):1145-53. PubMed ID: 18501812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcium oxalate supersaturation increases early after Roux-en-Y gastric bypass.
    Agrawal V; Liu XJ; Campfield T; Romanelli J; Enrique Silva J; Braden GL
    Surg Obes Relat Dis; 2014; 10(1):88-94. PubMed ID: 23953730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperoxaluric nephrolithiasis is a complication of Roux-en-Y gastric bypass surgery.
    Sinha MK; Collazo-Clavell ML; Rule A; Milliner DS; Nelson W; Sarr MG; Kumar R; Lieske JC
    Kidney Int; 2007 Jul; 72(1):100-7. PubMed ID: 17377509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperoxaluria in kidney stone formers treated with modern bariatric surgery.
    Asplin JR; Coe FL
    J Urol; 2007 Feb; 177(2):565-9. PubMed ID: 17222634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enteric hyperoxaluria, nephrolithiasis, and oxalate nephropathy: potentially serious and unappreciated complications of Roux-en-Y gastric bypass.
    Nelson WK; Houghton SG; Milliner DS; Lieske JC; Sarr MG
    Surg Obes Relat Dis; 2005; 1(5):481-5. PubMed ID: 16925274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bariatric surgery, hyperoxaluria, and nephrolithiasis: a plea for close postoperative management of risk factors.
    Kleinman JG
    Kidney Int; 2007 Jul; 72(1):8-10. PubMed ID: 17597787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypocitraturia and hyperoxaluria after Roux-en-Y gastric bypass surgery.
    Maalouf NM; Tondapu P; Guth ES; Livingston EH; Sakhaee K
    J Urol; 2010 Mar; 183(3):1026-30. PubMed ID: 20096421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperoxaluria is a long-term consequence of Roux-en-Y Gastric bypass: a 2-year prospective longitudinal study.
    Duffey BG; Alanee S; Pedro RN; Hinck B; Kriedberg C; Ikramuddin S; Kellogg T; Stessman M; Moeding A; Monga M
    J Am Coll Surg; 2010 Jul; 211(1):8-15. PubMed ID: 20610243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fat malabsorption and increased intestinal oxalate absorption are common after Roux-en-Y gastric bypass surgery.
    Kumar R; Lieske JC; Collazo-Clavell ML; Sarr MG; Olson ER; Vrtiska TJ; Bergstralh EJ; Li X
    Surgery; 2011 May; 149(5):654-61. PubMed ID: 21295813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bariatric Surgery in Patients with a History of Nephrolithiasis: 24-h Urine Profiles and Radiographic Changes After Roux-en-Y Gastric Bypass Versus Sleeve Gastrectomy.
    Uy M; Di Lena R; Hoogenes J; Alharbi B; Gmora S; Shayegan B; Matsumoto ED
    Obes Surg; 2021 Apr; 31(4):1673-1679. PubMed ID: 33387265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A prospective study of risk factors for nephrolithiasis after Roux-en-Y gastric bypass surgery.
    Park AM; Storm DW; Fulmer BR; Still CD; Wood GC; Hartle JE
    J Urol; 2009 Nov; 182(5):2334-9. PubMed ID: 19762043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Steatorrhea and hyperoxaluria occur after gastric bypass surgery in obese rats regardless of dietary fat or oxalate.
    Canales BK; Ellen J; Khan SR; Hatch M
    J Urol; 2013 Sep; 190(3):1102-9. PubMed ID: 23499748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gastric band placement for obesity is not associated with increased urinary risk of urolithiasis compared to bypass.
    Penniston KL; Kaplon DM; Gould JC; Nakada SY
    J Urol; 2009 Nov; 182(5):2340-6. PubMed ID: 19762051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperoxaluria after modern bariatric surgery: case series and literature review.
    Whitson JM; Stackhouse GB; Stoller ML
    Int Urol Nephrol; 2010 Jun; 42(2):369-74. PubMed ID: 19572208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of preoperative metabolic profiling to reduce the risk of kidney stones after bariatric surgery in patients with a history of stone formation.
    Campschroer T; Van Balken MR; Deden LN; Hazebroek EJ; De Boer H
    Surg Obes Relat Dis; 2023 Jun; 19(6):633-639. PubMed ID: 36609096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective evaluation of urinary metabolic indices in severely obese adolescents after weight loss surgery.
    DeFoor WR; Asplin JR; Kollar L; Jackson E; Jenkins T; Schulte M; Inge T
    Surg Obes Relat Dis; 2016 Feb; 12(2):363-7. PubMed ID: 26077697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Age, Body Mass Index, and Gender Predict 24-Hour Urine Parameters in Recurrent Idiopathic Calcium Oxalate Stone Formers.
    Otto BJ; Bozorgmehri S; Kuo J; Canales M; Bird VG; Canales B
    J Endourol; 2017 Dec; 31(12):1335-1341. PubMed ID: 29084490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nephrolithiasis after bariatric surgery: A review of pathophysiologic mechanisms and procedural risk.
    Bhatti UH; Duffy AJ; Roberts KE; Shariff AH
    Int J Surg; 2016 Dec; 36(Pt D):618-623. PubMed ID: 27847289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urinary lithogenic risk profile in recurrent stone formers with hyperoxaluria: a randomized controlled trial comparing DASH (Dietary Approaches to Stop Hypertension)-style and low-oxalate diets.
    Noori N; Honarkar E; Goldfarb DS; Kalantar-Zadeh K; Taheri M; Shakhssalim N; Parvin M; Basiri A
    Am J Kidney Dis; 2014 Mar; 63(3):456-63. PubMed ID: 24560157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.